Current data with inulin-type fructans and calcium, targeting bone health in adults

Journal of Nutrition

Volumn 137, Issue 11, 2007, Pages

  Coxam, Véronique ^a  

^a INRA and University of Auvergne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FRUCTAN; INULIN; SHORT CHAIN FATTY ACID;

BIOAVAILABILITY; BONE DENSITY; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CALCIUM BONE LEVEL; CALCIUM TRANSPORT; CONFERENCE PAPER; DIET SUPPLEMENTATION; HYDROLYSIS; LARGE INTESTINE; MAMMAL; NONHUMAN; PH;

MAMMALIA;

EID: 35848947202     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.11.2527s     Document Type: Conference Paper

References (72)

1. Heaney R. Aging and calcium balance. In: Rosen C, Glowacki J, Bilezikian JP, editors. The aging skeleton. San Diego: Academic Press; 1999. p. 19-26.
2. Consensus Development Conference. Diagnosis prophylaxis and treatment of osteoporosis. Am J Med. 1993;94:646-50.
3. Consensus development statement. Who are candidates for prevention and treatment for osteoporosis? Osteoporosis Int. 1997;7:1-6.
4. Report from the European Community. Building strong bones and preventing fractures. Summary report on osteoporosis in the European Community - action for prevention. EUR OP Eds, Luxembourg. ISBN 92-828-5334-9. 1999.
5. Coxam V, Horcajada MN. Prevention nutritionnelle de l'ostéoporose. Cachon (France): EM inter, Lavoisier editions; 2004.
6. Heaney RP, Weaver C. Newer perspectives on calcium nutrition and bone quality. J Am Coll Nutr. 2005;24 Suppl:574S-81S.
7. Eaton SB, Nelson DA. Calcium in evolutionary perspective. Am J Clin Nutr. 1991;54:281S-7S.
8. Heaney RP. Nutrition and risk for osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. San Diego: Academic Press; 1996. p. 483-509.
9. Bronner F. Intestinal calcium absorption: mechanisms and applications. J Nutr. 1987;117:1347-52.
10. Feldman D, Malloy PJ, Gross C. Vitamin D: metabolism and action. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. San Diego: Academic Press; 1999. p. 483-509.
11. Silververg SJ, Fitzpatrick LA, Bilezikian JP. The role of parathyroid hormone and vitamin D in the pathogenesis of osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. San Diego: Academic Press; 1999. p. 483-509.
12. Johnson MA, Kimlin MG. Vitamin D, aging, and the 2005 dietary guidelines for Americans. Nutr Rev. 2006;64:410-21.
13. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in txo seasonal subpopulations from NHANES III. Bone. 2002;30:771-7.
14. Melhus H, Michaelson K, Kindmark A, Bergstrom R, Holmberg L, Mallmin H, Wolk A, Ljunghall S. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip frature. Ann Intern Med. 1998;129:770-8.
15. Hidaka H, Hirayama M, Tokunaga T, Eida T. The effects of undigestible fructooligosaccharides on intestinal microflora and various physiological functions on human health. Adv Exp Med Biol. 1990;270:105-17.
16. Cashman K. Prebiotics and calcium bioavailability. Curr Issues Intest Microbiol. 2003;4:21-32.
17. Coxam V. Inulin-type fructans and bone health: state of the art and perspectives in the management of osteoporosis. Br J Nutr. 2005;93:Suppl 1:S111-23.
18. Cummings JH, Macfarlane GT, Englyst HN. Prebiotic digestion and fermentation. Am J Clin Nutr. 2001;73:415S-420S.
19. Cashman KD. A prebiotic substance persistently enhances intestinal calcium absorption and increases bone mineralization in young adolescents. Nutr Rev. 2006;64:189-96.
20. Roberfroid M. Dietary fibers, inulin, and oligofructose: a review comparing their physiological effects. Crit Rev Food Sci Nutr. 1993;33:103-48.
21. Roberfroid M. Health benefits of non-digestible oligosaccharides. In: Kritchevsky, Bonfield, editors, Dietary fiber in health and disease. New York: Plenum Press; 1997. p. 211-219.
22. Roberfroid M. Functional foods: concepts and application to inulin and oligofructose. Br J Nutr. 2002;87 Suppl:S139-43.
23. Scholz-Ahrens K, Schaafsma G, Van den Heuvel EGHM, Schrezenmeier J. Effects of prebiotics on mineral metabolism. Am J Clin Nutr. 2001;73 Suppl:459S-64S.
24. Cashman KD. Calcium intake, calcium bioavailability and bone health. Br J Nutr. 2002;87 Suppl:S169-77.
25. Scholz-Ahrens K, Schrezenmeier J. Inulin, oligofructose and mineral metabolism-experimental data and mechanism. Br J Nutr. 2002;87 Suppl:S179-86.
26. Rémésy C, Levrat MA, Gamet L, Demigné C. Cecal fermentations in rats fed oligosaccharides (inulin) are modulated by dietary calcium level. Am J Physiol. 1993;264:G855-62.
27. Ohta A, Ohtsuki M, Baba S, Adachi T, Sakata T, Sakaguchi E. Calcium and magnesium absorption from the colon and rectum are increased in rats fed fructo-oligosaccharides. J Nutr. 1995;125:2417-24.
28. Lutz T, Scharrer F. The effect of SCFA on Ca absorption by the rat colon. Exp Physiol. 1991;76:615-8.
29. Ohta A, Motohashi Y, Ohtsuki M, Hirayama M, Adachi T, Sakuma K. Dietary fructooligosaccharides change concentration of calbindin-D9K differently in the mucosa of the small and large intestine of rat. J Nutr. 1998;128:934-9.
30. Raschka L, Daniel H. Mechanisms underlying the effects of inulin-type fructans on calcium absorption in the large intestine of rats. Bone. 2005;37:728-35.
31. Ten Bruggencate SJM, Bovee-Oudenhoven IMJ, Lettink-Wissink MLG, Van der Meer R. Dietary fructooligosaccharides increase intestinal permeability in rats. J Nutr. 2005;135:837-42.
32. Scholz-Ahrens K, Açil Y, Schrezenmeier J. Effect of oligofructose or dietary calcium on repeated calcium and phosphorus balances, bone mineralisation and trabecular structure in ovariectomized rats. Br J Nutr. 2002;88:365-77.
33. Coudray C, Bellanger J, Castiglia-Delavaud C, Rëmësy C, Vermorel M, Rayssiguier Y. Effect of soluble or partly soluble dietary fibres supplementation on absorption and balance of calcium, magnesium, iron, and zinc in healthy young men. Eur J Clin Nutr. 1997;51:375-80.
34. Van den Heuvel EG, Schaafsma G, Muys T, Van Dokkum W. Non-digestibles oligosaccharides do not interfere with calcium and nonhemeiron in young, healthy men. Am J Clin Nutr. 1998;67:445-51.
35. Teuri U, Kärkkäinen M, Lamberg-Allardt C, Korpela R. Addition of inulin to breakfast does not acutely affect serum ionized calcium and parathyroid hormone concentrations. Ann Nutr Metab. 1999;43:356-64.
36. Ellegard L, Andersson H, Bosaeus I. Inulin and oligofructose do not influence the absorption of cholesterol, and the excretion of cholesterol, Fe, Ca, Mg and bile acides but increases energy excretion in man. A blinded controlled cross-over study in ileostomy subjects. Eur J Clin Nutr. 1997;51:1-5.
37. Tahiri M, Tressol JC, Arnaud J, Bornet FR, Bouteloup-Demange C, Feillet-Coudray C, Brandolini M, Ducros V, Pépin D, et al. Effect of short-chain fructooligosaccharides on intestinal calcium absorption and calcium status in postmenopausal women a stable-isotope study. Am J Clin Nutr. 2003;77:449-57.
38. Van den Heuvel EG, Muys T, Van Dokkum W, Schaafsma G. Lactulose stimulates calcium absorption in postmenopausal women. J Bone Miner Res. 1999;14:1211-6.
39. Van den Heuvel EG, Schoterman MH, Muijs T. Transgalactooligosaccharides stimulate calcium absorption in postmenopausal women. J Nutr. 2000;130:2938-42.
40. Kim YY, Jang KH, Lee EY, Cho Y, Kang SA, Ha WK, Choue R. The effect of chicory fructan fiber on calcium absorption and bone metabolism in Korean postmenopausal women. Nutr Sci. 2004;7:151-7.
41. Holloway L, Moynihan S, Kent K, Hsu AR, Friedlander AL. Effects of oligofructose enriched inulin on mineral absorption and markers of bon turnover in postmenopausal women. Br J Nutr. 2007;97:365-72.
42. Dahl WJ, Whiting SJ, Isaac TM, Weeks SJ, Arnold CJ. Effects of thickened beverages fortified with inulin on beverage acceptance, gastrointestinal function, and bone resorption in institutionalised adults. Nutrition. 2005;21:308-11.
43. Abrams SA, Griffin IJ, Hawthorne KM, Liang L, Gunn SK, Darlington G, Ellis KJ. A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr. 2005;82:471-6.
44. Albright F, Reifenstein EC. Metabolic bone disease; osteoporosis. In: Albright F, Reifenstein EC, editors. The parathyroid glands and metabolic bone disease. Baltimore: Williams & Wilkins; 1948. p. 145-204.
45. Bryant HU, Dere WH. Selective estrogen receptor modulators: an alternative to hormone replacement therapy. Proc Soc Exp Biol Med. 1998;217:45-52.
46. Setchell KDR. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr. 1998;68 Suppl:1333S-46S.
47. Setchell KDR, Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr. 2003;78 Suppl:593S-609S.
48. Miksicek RJ. Commonly occuring plant flavonoids have estrogenic activity. Mol Pharmacol. 1993;44:37-43.
49. Knight DC, Eden JA. Phytoestrogens - a short review. Maturitas. 1995;22:167-75.
50. Seidl MM, Stewart DE. Alternative treatments for menopausal symptoms. Can Fam Physician. 1998;44:1299-308.
51. Moggs JG, Ashby J, Tinwell H, Lim FL, Moore DJ, Kimber I, Orphanides G. The need to decide if all estrogens are intrinsically similar. Environ Health Perspect. 2004;112:1137-42.
52. Coxam V. Prevention of osteopenia by phyto-oestrogens: animal studies. Br J Nutr. 2003;89 Suppl:S75-85.
53. Coxam V, Gerber M. Effet des phytoestrogènes sur l'ostéoporose. In: Thomann C, editor. Sécurité et bénéfices des phytoestrogènes apportés par l'alimentation. Recommandation. Nancy (France): Rapport AFSSA, 2005. p. 221-249.
54. Branca F, Lorenzetti S. Health effect of phytoestrogens. In: Elmadfa I, editor. Diet diversification and health promotion. Volume 57. Basel: Forum Nutrition; 2005. p. 1-12.
55. Day AJ, DuPont MS, Ridley S, Rhodes M, Rhodes MJ, Morgan MR, Williamson G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett. 1998;436:71-5.
56. Setchell KDR, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol. A clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132:3577-84.
57. Uehara M, Ohta A, Sakai K, Suzuki K, Watanabe S, Adlercreutz H. Dietary fructooligosaccharides modify intestinal bioavailability of a single dose of genistein and daidzein and affect their urinary excretion and kinetics in blood of rats. J Nutr. 2001;131:787-95.
58. Xu X, Wang HJ, Murphy PA, Cook L, Hendrich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr. 1994;124:825-32.
59. Joannou GE, Kelly GE, Reeder AY, Waring M, Nelson C. A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J Steroid Biochem Mol Biol. 1995;54:167-84.
60. Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med. 1998;217:335-9.
61. Axelson M, Kirk DN, Farrant RD, Cooley G, Lawson AM, Setchell KDR. The identification of the weak oestrogen equol (7-hydroxy-3-(4′-hydroxyphenyl) chroman) in human urine. Biochem J. 1982;201:353-7.
62. Rowland I, Wiseman H, Sanders T, Adlercreutz H, Bowey E. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer. 2000;36:27-32.
63. Setchell KD, Brown NM, Zimmer-Nechemias L, Brashear WT, Wolfe BE, Kirschner AS, Heubi JE. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr. 2002;76:447-53.
64. Lydeking-Olsen E, Jensen JBE, Setchell KDR, Damhus M, Erdman JW. Isoflavone-rich soymilk prevents bone-loss in the lumbar spine of postmenopausal women. A 2 year study [abstract]. J Nutr. 2002;132:581S.
65. Xu X, Harris KS, Wang HJ, Murphy PA, Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr. 1995;125:2307-15.
66. Tamura A, Nishimukai M, Shigematsu N, Hara H. Supplementation of difructose anhydre III enhanced elevation of plasma equol concentrations and lowered plasma total colesterol in isoflavone-fed rats. Br J Nutr. 2006;96:442-9.
67. Tamura M, Hirayama K, Itoh K. Effects of soy oligosaccharides on plasma and cecal isoflavones, and cecal enzyme activities in mice. J Nutr Sci Vitaminol (Tokyo). 2003;49:168-71.
68. Zafar TA, Weaver CM, Jones K, Moore 2nd DR, Barnes S. Inulin effects on bioavailability of soy isoflavones and their calcium absorption enhancing ability. J Agric Food Chem. 2004;52:2827-31.
69. Ohta A, Uehara M, Sakai K, Takasaki M, Adlercreutz H, Morohashi T, Ishimi Y. A combination of dietary fructooligosaccharides and isoflavones conjugates increases femoral bone mineral density and equol production in ovariectomized mice. J Nutr. 2002;132:2048-54.
70. Mathey J, Katicoulibali S, Puel C, Bennetau C, Lebecque P, Davicco MJ, Horcajada MN, Garel JM, Coxam V. Dietary fructooligosaccharides improve soy-osteopenia prevention in the ovariectomised rat. J Bone Miner Res. 2003;18 Suppl2:SU358.
71. Devareddy L, Khalil DA, Korlagunta K, Hooshmand S, Bellmer DD, Arjmandi BH. The effects of fructo-oligosaccharides in combination with soy protein on bone in osteopenic ovariectomized rats. Menopause. 2006;13:692-9.
72. Mathey J, Bennetau-Pelissero C, Davicco MJ, Puel C, Kati-Coulibali S, Horcajada MN, Coxam V. Effect of pre- and probiotics on isoflavones bioavailability, consequences on bone metabolism in postmenopausal women. J Bone Miner Res. 2004;19 Suppl1: SU460.